Methyl 2,2-dimethyl-2,3-dihydrobenzofuran-4-carboxylate, 97%, 100mg

3-[(4-methoxyphenyl)thio]propanoic acid, 95.0%, 250mg

Oxyde de gadolinium, ROTI®REMETIC, 99,99 %, 25 g, emballage plastique.

(1R,3R,Z)-5-((E)-2-((1R,7aR)-7a-methyl-1-((R)-6-methylheptan-2-yl)dihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol, 98%, 50mg

7-Benzoyl-1,3-dihydro-indol-2-one, 97.0%, 1g

Pyrido[2,3-b]pyrazine, 97.0%, 5g

4-bromo-N-cyclopentyl-2-fluorobenzenesulfonamide, 95.0%, 1g

2-Hydrazino-adenosine, 95.0%, 250mg

(R)-1-Methylpiperidine-2-carboxylic acid, 95.0%, 1g

4-(Benzyloxy)-2-fluorobenzoic acid, 95%, 1g

3-(4-Chlorophenoxy)azetidine hydrochloride, 95%, 100mg

4-bromo-N'-butylbenzohydrazide, 10mg

BICTEGRAVIR, 95%, 100mg